Sort   by:  
 Page size 
UnknownNew approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Not available
S-EPMC3466428 | biostudies-literature
UnknownPhase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Not available
S-EPMC4876357 | biostudies-literature
Unknown<i>Nunavimmi puvakkut kaggutimik aanniaqarniq: Qanuilirqitaa?</i> Lung cancer in Nunavik: How are we doing? A retrospective matched cohort study.
Not available
S-EPMC10890229 | biostudies-literature
UnknownEvolving strategies for management of desmoid tumor.
Not available
S-EPMC9546183 | biostudies-literature
UnknownA Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.
Not available
S-EPMC4718433 | biostudies-literature
UnknownAfatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
Not available
S-EPMC3594037 | biostudies-literature
UnknownTargeted therapies for the treatment of soft tissue sarcoma.
Not available
S-EPMC10034045 | biostudies-literature
UnknownEmerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma.
Not available
S-EPMC9905840 | biostudies-literature
UnknownThe Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer.
Not available
S-EPMC8322686 | biostudies-literature
UnknownOlaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Not available
S-EPMC5647653 | biostudies-literature
Sort   by:  
 Page size